The Amsterdam UMC TKI-PPP (Topconsortium voor Kennis en Innovatie) grants for Public-Private Partnerships seek to stimulate research collaborations between Amsterdam UMC researchers and commercial companies. The funding is provided by the Dutch government (Ministry of Economic Affairs) through the Rijksdienst voor Ondernemend Nederland (RVO) and the Topconsortium voor Kennis and Innovatie Life Sciences & Health (TKI-LSH, a.k.a. Health-Holland).

Researchers receive subsidies between € 300.000 and € 750.000 to perform a research project in collaboration with an industrial party. The grants are available to all Amsterdam UMC researchers.

Several research projects at Cancer Center Amsterdam were recently selected to receive TKI-PPP grants.

CLOSIT CLL Lymph node Organoids for Screens and Intelligent Testing Prof. Eric Eldering

MED-aNaL MEthylation Diagnostics for minimally-invasive aNaL cancer screening Prof. Renske D.M. Steenbergen

ULTRADOCUltrafast optical spectroscopy for depth resolved optical biopsyprof. dr. ir. H.J.C.M. (Dick) Sterenborg, Amsterdam UMC, location AMC

Cell-PET Imaging of NK cells with PET: towards better understanding of CAR-NK and NK cell therapy Dr. Danielle Vugts

AI-IMPACT Repurposing and discovery of multi-target kinase inhibitors against brain tumors Dr. Bart Westerman

The Toxicity Atlas Application of Artificial Intelligence to predict toxicities of combination therapies Dr. Bart Westerman

TKI-PPP grants awarded to Amsterdam UMC researchers - Innovation Exchange Amsterdam (ixa.nl)